RxDoctor Payments Data

Orville Bunker, MD

Family Medicine · Newton, IANPI 1902838527

Payments from drug & device makers

$897in general payments, 2019–2025

Across 75 payments — averaging $11.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$235
  • Pfizer$234
  • Astellas Pharma US Inc$100
  • GSK$62
  • Sunovion Pharmaceuticals Inc.$43
  • Boehringer Ingelheim$38
  • plus $186 from 9 others

What the payments were for

  • Food & beverage$897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$897 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$246,589
Medicare patients
525
Services billed
8,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban209$110,903
OzempicSemaglutide90$79,269
JardianceEmpagliflozin72$55,009
XareltoRivaroxaban36$37,658
Tresiba Flextouch U-200Insulin Degludec33$28,028
JanuviaSitagliptin Phosphate19$22,987
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,695
Breo ElliptaFluticasone/Vilanterol32$15,713
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$10,931
Bydureon BciseExenatide Microspheres13$10,793
MyrbetriqMirabegron31$9,960
Incruse ElliptaUmeclidinium Bromide12$9,752
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$9,740
Spiriva HandihalerTiotropium Bromide13$6,768
Tresiba Flextouch U-100Insulin Degludec11$6,013

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$234$110,903209 claims
Novo NordiskOzempic$15$79,26990 claims
Boehringer IngelheimJardiance$38$55,00972 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta$62$51,90081 claims
Johnson & JohnsonXarelto$11$37,65836 claims
Astellas Pharma US IncMyrbetriq$100$9,96031 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$14$3,74118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Newton

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →